Ovarian cancer
Chemotherapy inside the abdomen after surgery in patients with ovarian cancer to reduce chances of disease coming back
Who can joinWomen
AgeAsk the trial team
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine and surgery or a procedure
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)IndiaDirections ↗
Registry summary (technical)
Post-operative intraperitoneal chemotherapy after interval cytoreduction in epithelial ovarian cancer (POICE 2024): multicenter, randomized, phase III trial - POICE 2024
Sponsor: Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER
CTRI/2024/08/072237 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 5 Oct 2026 · read by us 5 Nov 2026